Summary
- Current Price
- As of today, FDMT price is $11.47, up +2.96% on
- Current Price All-Time High
- FDMT price is currently -79.19% below its historical high of $55.11 set on
- Market Cap
- FDMT current market cap is $600M, up +132.18% over the past 365 days
- Revenue
- FDMT current annual revenue is $85.21M, up +230194.59% year-over-year
- Next Earnings
- As of today, the next earnings release for FDMT has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | 4D Molecular Therapeutics, Inc. |
| Ticker | NASDAQ: FDMT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | 4dmoleculartherapeutics.com |
| Employees | 227 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $11.47 | |
| Price, 1D Change | +2.96% | |
| $600M | ||
| - | ||
| - | ||
| 2.11 | ||
| $85.21M | ||
| Revenue, 1Y Change | +230,194.59% | |
| -$2.42 | ||
| EPS, 1Y Change | +18.90% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$2.42 | ||
| EPS Estimate | -$3.95 | N/A |
| EPS Est. Change | -63.51% | N/A |
| $85.21M | ||
| Revenue Estimate | $11.78M | N/A |
| Revenue Est. Change | -86.17% | N/A |
| Current Price | $11.47 | |
| Price Target | $31.00 | - |
| Price Tgt. Change | +170.27% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.92 | -$2.98 | -1.97% | |
| -$3.26 | -$2.42 | +25.78% | |
| -$3.95 | N/A | -63.51% | |
| -$3.83 | N/A | -58.31% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.38M | $37.00K | -97.33% | |
| $37.74M | $85.21M | +125.76% | |
| $11.78M | N/A | -86.17% | |
| $17.62M | N/A | -79.33% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $11.47 | |
| $9.78 | ||
| $10.72 | ||
| $9.60 | ||
| $10.63 | ||
| -$0.05 | ||
| 2.11 | ||
| $0.69 | ||
| 58.76 | ||
| 34.29% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $85.21M | ||
| -$2.42 | ||
| $77.58M | ||
| 91.05% | ||
| -$159.55M | ||
| -187.24% | ||
| -$140.11M | ||
| -164.43% | ||
| -$151.92M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.04 | ||
| 9.39 | ||
| 9.39 | ||
| - | ||
| 4 | ||
| 4.13 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 6.80 | ||
| 1.33 | ||
| -1.34 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $505.66M | ||
| $402.66M | ||
| $566.71M | ||
| $413.13M | ||
| $61.05M | ||
| $43.99M | ||
| $21.41M | ||
| $5.59M | ||
| $11.16M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $225.32M | ||
| $237.13M | ||
| $7.63M | ||
| $0.00 | ||
| $7.63M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$109.08M | ||
| -$92.97M | ||
| $112.96M | ||
| $536.00K | ||
| -$109.62M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| B. Riley Securities | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| RBC Capital | → | |
| Chardan Capital | → | |
| Barclays | ||
| Chardan Capital | → | |
| RBC Capital | → | |
| Chardan Capital | → | |
| Barclays | → |
Analyst sentiment
Institutional ownership
No data
Screeners with FDMT
FAQ
- What is the ticker symbol for 4D Molecular Therapeutics, Inc.?
- The ticker symbol for 4D Molecular Therapeutics, Inc. is NASDAQ:FDMT
- Does 4D Molecular Therapeutics, Inc. pay dividends?
- No, 4D Molecular Therapeutics, Inc. does not pay dividends
- What sector is 4D Molecular Therapeutics, Inc. in?
- 4D Molecular Therapeutics, Inc. is in the Healthcare sector
- What industry is 4D Molecular Therapeutics, Inc. in?
- 4D Molecular Therapeutics, Inc. is in the Biotechnology industry
- What country is 4D Molecular Therapeutics, Inc. based in?
- 4D Molecular Therapeutics, Inc. is headquartered in United States
- When did 4D Molecular Therapeutics, Inc. go public?
- 4D Molecular Therapeutics, Inc. initial public offering (IPO) was on December 11, 2020
- Is 4D Molecular Therapeutics, Inc. in the S&P 500?
- No, 4D Molecular Therapeutics, Inc. is not included in the S&P 500 index
- Is 4D Molecular Therapeutics, Inc. in the NASDAQ 100?
- No, 4D Molecular Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is 4D Molecular Therapeutics, Inc. in the Dow Jones?
- No, 4D Molecular Therapeutics, Inc. is not included in the Dow Jones index
- When was 4D Molecular Therapeutics, Inc. last earnings report?
- 4D Molecular Therapeutics, Inc.'s most recent earnings report was on August 10, 2026
- When does 4D Molecular Therapeutics, Inc. report earnings?
- The date for 4D Molecular Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- FDMT Official Website www.4dmoleculartherapeutics.com
- FDMT Profile on Yahoo Finance finance.yahoo.com/quote/FDMT
- FDMT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/fdmt